Gilead Sciences (NASDAQ: GILD) CEO sells 10,000 shares under 10b5-1 plan

robot
Abstract generation in progress

Gilead Sciences CEO Daniel O’Day sold 10,000 shares of common stock on March 27, 2026, at an average price of $136.8162 per share, as part of a pre-arranged Rule 10b5-1 trading plan. Following this transaction, O’Day directly holds 642,567 shares. The sale, made under a plan adopted in February 2025, reflects an aggregate value of approximately $1.37 million.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin